Crossref
A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions
British Journal of Cancer Research · 2018
DOI: 10.31488/bjcr.118 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Cancer Research, 2018.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2018). A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions. British Journal of Cancer Research. https://doi.org/10.31488/bjcr.118
Vancouver
A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions. British Journal of Cancer Research. 2018. doi:10.31488/bjcr.118
BibTeX
@article{euvimed2018,
title = {A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions},
journal = {British Journal of Cancer Research},
year = {2018},
doi = {10.31488/bjcr.118}
}
EUVIMED